View in EDS HTML Full Text PDF Full Text

Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID.

Saved in:
Bibliographic Details
Title: Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID.
Authors: Calméjane L; Faculté de Médecine, Université Paris Cité, Paris, France., Reenaers C; Gastroenterology Department, CHU Sart-Tilman, Liège, Belgium., Gay C; Department of Gastroenterology, CHU de Lyon, Lyon-Sud Hospital, Pierre-Benite, France and INSERM U1111-CIRI, Lyon, France., Amiot A; Department of Gastroenterology, Hôpitaux Universitaires Bicêtre, AP-HP, Université Paris Saclay, Le Kremlin Bicêtre, France., Nuzzo A; Department of Gastroenterology, IBD and Intestinal Failure, Intestinal Stroke Center, AP-HP Hôpital Beaujon, Clichy, France., Vuitton L; Department of Gastroenterology, Besancon University Hospital, Besancon, France., Atanasiu C; Department of Gastroenterology, Hôpital Saint-Joseph, Paris, France., Stefanescu C; Institut des MICI, Clinique Ambroise Paré-Hartmann, Neuilly-sur-Seine, France., Altwegg R; Department of Gastroenterology, CHU de Montpellier, Montpellier, France., Guillo L; Department of Gastroenterology, University Hospital of Marseille Nord, Assistance Publique-Hôpitaux de Marseille (AP-HM), University of Aix-Marseille, Marseille, France., Serrero M; Department of Gastroenterology, University Hospital of Marseille Nord, Assistance Publique-Hôpitaux de Marseille (AP-HM), University of Aix-Marseille, Marseille, France., Bouguen G; Department of Gastroenterology, CHU Rennes and University of Rennes, INSERM, CIC1414, NUMECAN Institute, Rennes, France., Nachury M; Université de Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, Lille, France., Le Cosquer G; Department of Gastroenterology and Pancreatology, Hôpital Rangueil, Université Toulouse Paul Sabatier, Toulouse, France., Roblin X; Department of Gastroenterology, Saint-Etienne University Hospital, Saint-Etienne, France., Abitbol V; Department of Gastroenterology, Cochin University Hospital, Paris, France., Hammoudi N; Department of Gastroenterology, Hôpital Saint-Louis, Université Paris Cité, Paris, France., Simon M; Department of Gastroenterology, Institut Mutualiste Montsouris, Paris, France., Fumery M; Department of Gastroenterology, Amiens University Hospital, and PeriTox, Université de Picardie Jules Verne, Amiens, France., Savoye G; Department of Gastroenterology Rouen University Hospital, UMR 1073 University of Rouen Normandy, Rouen, France., Benezech A; Department of Gastroenterology, Centre Hospitalier Avignon, Avignon, France., Cavicchi M; Department of Gatroenterology, Clinique de Bercy, Creteil, France., Charkaoui M; Department of Hepatogastroenterology, Dijon University Hospital, Dijon, France., Buisson A; Université Clermont Auvergne, Service d'Hépato-Gastroentérologie, Clermont-Ferrand, France., Caron B; Department of Gastroenterology, Nancy University Hospital, and INSERM, NGERE, University of Lorraine, Nancy, France., Coffin B; Department of Gastroenterology, AP-HP Nord, Hôpital Louis Mourier, Colombes, France., Geyl S; Hepato-Gastro-Entérologie, Limoges University Hospital, Limoges, France., Goutorbe F; Department of HepatoGastroenterology, Cote Basque Hospital, Bayonne, France., Hupé M; Université Grenoble Alpes/Hepato-Gastroenterology and Digestive Oncology Department, CHU Grenoble Alpes/Institute for Advanced Biosciences, CNRS UMR 5309-INSERM U1209, Grenoble, France., Vidon M; Department of Gastroenterology, Intercommunal Hospital, Creteil, France., Laharie D; CHU de Bordeaux, Hôpital Haut-Lévêque, Service d'Hépato-gastroentérologie et oncologie digestive-Université de Bordeaux, Bordeaux, France., Kirchgesner J; Gastroenterology Department, Sorbonne Université, Saint-Antoine Hospital, Paris, France., Uzzan M; Gastroenterology Department, Paris Est Créteil University UPEC, Henri Mondor Hospital, Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for ImmUne DisordErs, Créteil, France.
Corporate Authors: GETAID‐AFTER‐VEDO Study Group
Source: United European gastroenterology journal [United European Gastroenterol J] 2026 Apr; Vol. 14 (3), pp. e70203.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 101606807 Publication Model: Print Cited Medium: Internet ISSN: 2050-6414 (Electronic) Linking ISSN: 20506406 NLM ISO Abbreviation: United European Gastroenterol J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2050-6414
DOI:10.1002/ueg2.70203